-
Mashup Score: 1
The FDA has approved mirdametinib for patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas.
Source: www.onclive.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
A marketing authorization application has been submitted to the EMA seeking the approval of eflornithine for patients with high-risk neuroblastoma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
EU Approval Is Sought for Eflornithine in High-Risk Neuroblastoma #btsm #oncology https://t.co/YUH8KyxnVw
-
-
Mashup Score: 6
A marketing authorization application has been submitted to the EMA seeking the approval of eflornithine for patients with high-risk neuroblastoma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
EU Approval Is Sought for Eflornithine in High-Risk Neuroblastoma #btsm #oncology https://t.co/YUH8KyxnVw
-
-
Mashup Score: 3FDA Approves Companion Diagnostic for Tovorafenib in BRAF-Altered Pediatric Low-Grade Glioma - 26 day(s) ago
Tovorafenib generated durable drug holiday responses in pediatric patients with BRAF-altered relapsed/refractory low-grade glioma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
FDA Approves Companion Diagnostic for Tovorafenib in BRAF-Altered Pediatric Low-Grade Glioma @US_FDA #btsm #oncology https://t.co/VEHUhlcoax
-
-
Mashup Score: 6EU Approval Is Sought for Eflornithine in High-Risk Neuroblastoma - 1 month(s) ago
A marketing authorization application has been submitted to the EMA seeking the approval of eflornithine for patients with high-risk neuroblastoma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
EU Approval Is Sought for Eflornithine in High-Risk Neuroblastoma #btsm #oncology https://t.co/YUH8KyxnVw
-
-
Mashup Score: 0FDA Grants Orphan Drug Designation to MB-108 for Malignant Glioma - 3 month(s) ago
The FDA has granted orphan drug designation to the herpes simplex virus type 1 oncolytic virus MB-108 for the management of malignant glioma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
FDA Grants Orphan Drug Designation to MB-108 for Malignant Glioma. @US_FDA #btsm #oncology https://t.co/D40XBoPbGn
-
-
Mashup Score: 0FDA Grants Orphan Drug Designation to MB-108 for Malignant Glioma - 3 month(s) ago
The FDA has granted orphan drug designation to the herpes simplex virus type 1 oncolytic virus MB-108 for the management of malignant glioma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
FDA Grants Orphan Drug Designation to MB-108 for Malignant Glioma. @US_FDA #btsm #oncology https://t.co/D40XBoPbGn
-
-
Mashup Score: 0FDA Grants Orphan Drug Designation to MB-108 for Malignant Glioma - 3 month(s) ago
The FDA has granted orphan drug designation to the herpes simplex virus type 1 oncolytic virus MB-108 for the management of malignant glioma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
FDA Grants Orphan Drug Designation to MB-108 for Malignant Glioma. @US_FDA #btsm #oncology https://t.co/D40XBoPbGn
-
-
Mashup Score: 1
An update on PFS and OS data from the phase 1 MAGIC-G1 study of MTX110 in recurrent glioblastoma has been released.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
MAGIC-G1 Study Provides Updated Findings With MTX110 in Recurrent Glioblastoma #btsm #oncology https://t.co/sUytFnOOiC
-
-
Mashup Score: 1
An update on PFS and OS data from the phase 1 MAGIC-G1 study of MTX110 in recurrent glioblastoma has been released.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
MAGIC-G1 Study Provides Updated Findings With MTX110 in Recurrent Glioblastoma #btsm #oncology https://t.co/sUytFnOOiC
-
RT @OncLive: BREAKING: 🚨 @US_FDA Approves Mirdametinib for NF1-Associated Plexiform Neurofibromas #btsm #oncology https://t.co/oLlLuumYpO h…